Richard Pollard
Chief, Division of Infectious Diseases
Principal Investigator
AIDS Clinical Trials Unit
Principal Investigator
Northern California Center for AIDS Research

email: rbpollard@ucdavis.edu

Specialty: Infectious Diseases

Undergraduate Education: University of Maryland, 1966

Medical Education: University of Maryland, 1970

Internships: Ohio State University, 1971

Residencies: Emory University Affiliated Hospitals, 1975

Board Certifications: American Board of Internal Medicine, June 1975

Professional Memberships: American College of Physicians, Infectious Diseases Society of America, American Society for Virology, American Association of Immunologists, Southern Society for Clinical Investigation, American Society for Microbiology, American Federation for Clinical Research, Pan American Group for Rapid Viral Diagnosis, International Society for Interferon Research, Sigma Xi, International Society for Antiviral Research, International AIDS Society, Phi Sigma Society

Fellowships: Stanford University Medical Center, 1978

Selected Publications: Nokta, M.A., Li, Xiao-Dong, Nichols, J., Mallen, M., Pou, A., Asmuth, D. and Pollard, R.B. Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals. AIDS, 15:161-169, 2001.

Nokta, M.A., Li, Xiao-Dong, Nichols, J., Pou, A., Asmuth, D. and Pollard, R.B. Homeostasis of naïve and memory T cell subpopulations in peripheral blood and lymphoid tissues in the context of Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases, 183:1336-42, 2001.

Utsunomiya, T., Kobayashi, M., Ito, M., Herndon, D.N., Pollard R.B., Suzuki, F. Glycyrrhizin restores the impaired IL-12 production in thermally injured mice. Cytokine, 14(1):49-55, 2001.

Raffi, F., Reliquet, V., Podzamczer, D., Pollard, R.B. Efficacy of Nevirapine-based HAART in HIV-1-infected, treatment-naïve persons with high and low baseline viral loads. HIV Clinical Trials, 2(4):317-322, 2001.

Para, M.F., Kalish, L.A., Collier, A.C., Pollard, R.B., Kumar, P.N., Mintz, L., Wallach, F.R., and Drew, W.L. for the Viral Activation Transfusion Study (VATS) Group. Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions. JAIDS, 26:320-325, 2001.

Nokta, M.A., Li, X-D, Al-Harthi, L., Nichols, J., Asmuth, D., Landay, A., Pollard, R.B. Entrapment of Recent Thymic Emmigrants in Lymphoid Tissues from HIV-Infected Patients: Association with HIV Cellular Viral Load. AIDS, 16: 2119-2127, 2002.

Pollard, R.B. Can HIV Infection be Successfully Treated Once Daily? The AIDS Reader: 12: 489-508, 2002

Jacobson, M.A., Spritzler, J., Landay, A., Chan, E., Katzenstein, D., Schock, B., Fox, L., Roe, J., Kundu, S., Pollard, R.B., and the AACTG 325 Protocol Team. A Phase I, placebo controlled trial of multi dose recombinant human interleukin-12 in patients with HIV infection. AIDS 2002, 16:1147-1154

Koboyashi, M., Takahashi, H., Herndon, D.H., Pollard, R.B., and Suzuki, F. Effect of a combination therapy between IL-12 and soluble IL-4 receptor(sIL-4R) on Candida albicans and herpes simplex virus type 1 infections in thermally injured mice. Can. J. Microbiol., 48:886-894, 2002.

Valdez, H., Mitsuayasu, R., Landay, A., Sevin, A.D., Chan, E.S., Spritzler, J., Kalams, S.A., Pollard, R.B., Fahey, J., Fox, L., Namkung, A., Estep, S., Moss, R., Sahner, D., Lederman, M.M. Interleukin -2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s. J Infect. Dis. Jan 15;187(2):320-5, 2003.

Rossero, R., Asmuth, D., Grady, J., McKinsey, D.S., Green, S., Andron, L., Pollard, R. B. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature. International Journal of STD and AIDS; 4 (5) 350-355, 2003.

Nadler, J. P., Gathe, J. C., Pollard, R. B., Richmond, G. J., Liao, Q., Griffith, S., Lancaster, T., Hernandez, J. E., Pappa, K. A. Twice Daily Amprenavir 1200 mg versus AMprenavir 600 mg/ Ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs in HIV-1 infected subjects. BMC Infectious Diseases 3(10) 1-9, 2003.

Kalayjian, RC, Landay, A., Pollard, RB, Taub, DD, Gross, HH, Francis, IR6, Sevin, A., Pu, M., Spritzler, J., Chernoff, M., Namkung, A., Fox, L., Martinez, A., Waterman, K., Fiscus, SA, Slater, S., Rousseau, F., Lederman, MM for the Adult AIDS Clinical Trials Group Protocol 5015 and 5113 Teams. Age-Related Immune Dysfunction in Health and in HIV-Disease: Both Age and HIV are Associated with Naïve CD8+ Cell Depletion and Reduced Expression of CD28 on CD8+ Cells.; JID;187:1924-1933, 2003.

Kobayashi, M., Takahashi, H., Herndon, D., Pollard, R.B., and Suzuki, F. Therapeutic effects of IL-12 combined with benzoylmesaconine, a non-toxic aconitine-hydrolysate, against herpes simplex virus type 1 infection in mice following thermal injury. Burns 29:37-42, 2003.

Robbins, GK, De Gruttola, V., Shafer, R., Smeaton, L., Snyder, S., Pettinelli, C., Dube, M.P., Fischl, M., Pollard, R.B., Delapenha, R., Gedeon, L., van der Horst, C., Murphy, R., Becker, M.I., D'Aquila, R.T., Vella, S., Merigan, T.C., and Hirsch, M.S. Strategies for Initial Antiretroviral Treatment of HIV-1 Infection: Comparison of Sequential Three-drug Regimens. New England Journal of Medicine; In Press.